OncLive TV

OncLive® TV is an editorial video program featuring one-on-one live and/or virtual interviews with key opinion leaders in the oncology field for their expert insight on breaking news, regulatory updates, practice-changing data presented at medical meetings, and other pivotal topics in a cancer specialty, including breast cancer, lung cancer, genitourinary cancers, gastrointestinal cancers, gynecologic cancers, and hematologic cancers.

Dr. Li Discusses ALK Gene Mutation Tests

August 29th 2011

Dr. Tianhong (Tina) Li from UC Davic Cancer Center Discusses ALK Gene Mutation Tests

Dr. Ellis Discusses the Future of the PI3-Kinase Pathway

August 26th 2011

Dr. Matthew J. Ellis from Washington University Discusses the Future of the PI3-Kinase Pathway

Dr. Yoneda on Advances in the Diagnosis of Lung Cancer

August 26th 2011

Dr. Ken Y. Yoneda from UC Davis Cancer Center on Advances in the Diagnosis of Lung Cancer

Dr. Reckamp Discusses the Use of Hsp90 Inhibitors

August 25th 2011

Dr. Karen Reckamp from the City of Hope Cancer Center Discusses the Use of Hsp90 Inhibitors

Dr. Tripathy on Determining the Best HER2 Targeted Therapy

August 25th 2011

Dr. Debu Tripathy from USC Norris Cancer Center on Determining the Best HER2 Targeted Therapy

Dr. Ellis Discusses the Cell-Proliferation Marker Ki67

August 24th 2011

Dr. Matthew Ellis from Washington University Discusses the Cell-Proliferation Marker Ki67

Dr. Yoneda on Bronchoscopy Tools and Procedures

August 24th 2011

Dr. Ken Yoneda from UC Davis Cancer Center Discusses Bronchoscopy Tools and Procedures

Dr. O'Shaughnessy on Negative TNBC Iniparib Results

August 23rd 2011

Dr. Joyce O'Shaughnessy from Baylor Sammons Cancer Center on Negative TNBC Iniparib Trial Results

Dr. Reckamp on Current Heat Shock Protein Clinical Trials

August 22nd 2011

Dr. Karen Reckamp City of Hope cancer center on Current Heat Shock Protein Clinical Trials

Dr. Tripathy Discusses HER2 Targeted Therapies

August 22nd 2011

Dr. Debu Tripathy from UC Norris Cancer Center Discusses HER2 Targeted Therapies

Dr. Yoneda Discusses the Role of the Pulmonologist

August 19th 2011

Dr. Ken Yoneda from UC Davis Cancer Center Discusses the Role of the Pulmonologist

Dr. Reckamp Describes the Use of Heat Shock Proteins

August 19th 2011

Dr. Karen Reckamp from City of Hope Cancer Center Describes the Use of Heat Shock Proteins

Dr. Hendrix on Metastatic Cells in Microenvironments

August 18th 2011

Dr. Mary J. C. Hendrix from Northwestern University's Feinberg School of Medicine on Metastatic Tumor Cells in Microenvironments

Dr. Tripathy on Completing New Assays After Recurrence

August 18th 2011

Dr. Debu Tripathy from USC Norris Cancer Center on Completing New Assays After Recurrence

Dr. O'Shaughnessy on Avastin as Her Standard of Care

August 17th 2011

Dr. Joyce A. O'Shaughnessy from Baylor Sammons Cancer Center on Avastin as Her Standard of Care

Dr. Reckamp Discusses Heat Shock Proteins in Lung Cancer

August 17th 2011

Dr. Karen Reckamp from City of Hope Cancer center Discusses Heat Shock Proteins in Lung Cancer

Dr. Tripathy on the Future of Breast Cancer Meeting

August 16th 2011

Dr. Debu Tripathy from USC Norris Cancer Center Describes the Benefits of the PER Conferences

Dr. Wolff Discusses the Importance of HER2 Testing

August 15th 2011

Dr. Antonio C. Wolff from Sidney Kimmel Comprehensive Cancer Center Discusses the Importance of HER2 Testing

Dr. Tripathy on the Oncotype DX Assay Recurrence Score

August 15th 2011

Dr. Debu Tripathy from USC Norris Cancer Center on the Oncotype DX Assay Recurrence Score

Dr. O'Shaughnessy on Continued Access to Avastin

August 13th 2011

Dr. Joyce A. O'Shaughnessy from Baylor Sammons Cancer Center on Continued Access to Avastin